Abstract:Increasing evidences have indicated that only a phenotypic subset of cancer cells, termed as the cancer stem cells (CSCs), is capable of initiating tumor growth and provide a reservoir of cells that cause tumor recurrence after therapy. Epithelial–mesenchymal transition (EMT), a cell type change from an epithelial cobblestone phenotype to an elongated fibroblastic phenotype, plays a critical role not only in tumor metastasis but also in tumor recurrence and contributes to drug resistance. Accumulating evidence has shown that cells with an EMT phenotype are rich sources for CSCs, suggesting a biological link between EMT and CSCs; thus study on the link will help understand the cellular and molecular mechanisms of tumor metastasis and drug resistance. CD29 is involved in EMT through cross-talk with cadherins and CD44 has been reported as a successful used marker for CSCs. Here, we try to address whether combination of CD29 and CD44 could be used to identify cancer stem-like cells undergoing EMT in squamous cell carcinoma (SCC) and compare the molecular differences between CD29high/CD44high and CD29low/CD44low cells in SCC. Expression pattern of CD29 and CD44 was analyzed in tissues of skin SCC and cultured A431 cells by immunostaining. Subtype cells of CD29high/CD44high and CD29low/CD44low A431 were sorted by fluorescence-activated cell sorting and proliferating abilities were assayed by cell counting, colony forming and tumorigenicity in NOD/SCID mice. Finally, to probe more deeply into the molecular differences between CD29high/CD44high and CD29low/CD44low A431 cells, gene microarray analysis was applied to compare gene expression profiling. Staining of CD29 and CD44 showed similar heterogeneous expression pattern with positive cells located in the invasion front of SCC tissue as well as in cultured A431 cells. Sorted CD29high/CD44high A431 cells had higher proliferating ability in vitro and in NOD/SCID mice as compared with CD29low/CD44low cells. Gene profiling identified differentiated gene expressions between CD29high/CD44high and CD29low/CD44low A431 cells. These genes are involved in cell cycle, cell malignant transformation, metastasis, drug resistance and EMT, implying that CD29high/CD44high cells have properties of CSCs and EMT. Our present results demonstrated heterogeneous gene expression patterns and different biological behavior in SCC. Combination of CD29 and CD44 can be used as markers to enrich CSCs in human SCC. Moreover, CD29high/CD44high cells exhibit molecular characteristics of EMT, suggesting that CSC-associated pathways were involved in EMT. Studies on correlation of CSCs and the cells undergoing EMT may explain some aspects of tumor progression and drug resistance.

CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation

Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma

The Developmental Transcription Factor IRF6 Attenuates ABCG2 Gene Expression and Distinctively Reverses Stemness Phenotype in Nasopharyngeal Carcinoma.

Extracellular Serglycin Upregulates the CD44 Receptor in an Autocrine Manner to Maintain Self-Renewal in Nasopharyngeal Carcinoma Cells by Reciprocally Activating the MAPK/β-catenin Axis

Cancer Stem-Like Cells Enriched with CD29 and CD44 Markers Exhibit Molecular Characteristics with Epithelial–mesenchymal Transition in Squamous Cell Carcinoma

Protein C Receptor Maintains Cancer Stem Cell Properties Via Activating Lipid Synthesis in Nasopharyngeal Carcinoma

Biological Characteristics of CD133+ Cells in Nasopharyngeal Carcinoma

CDK5RAP2 is a Wnt target gene and promotes stemness and progression of oral squamous cell carcinoma

Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells

Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma

Increased Invasion and Tumorigenicity Capacity of CD44 + /CD24 - Breast Cancer MCF7 Cells in Vitro and in Nude Mice

Retraction Note: ERK1/2-Nanog Signaling Pathway Enhances CD44(+) Cancer Stem-Like Cell Phenotypes and Epithelial-to-mesenchymal Transition in Head and Neck Squamous Cell Carcinomas

Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.

Diverse Targets of β-Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse

CD44 Sorted Cells Have an Augmented Potential for Proliferation, Epithelial-Mesenchymal Transition, Stemness, and a Predominantly Inflammatory Cytokine and Angiogenic Secretome

CD276 Expression Enables Squamous Cell Carcinoma Stem Cells to Evade Immune Surveillance.

Epigenetic Regulation Of Cd271, A Potential Cancer Stem Cell Marker Associated With Chemoresistance And Metastatic Capacity

Elevated expression of Nrf2 mediates multidrug resistance in CD133+ head and neck squamous cell carcinoma stem cells

[CD44 Regulates Epithelial-Mesenchymal Transition and Metastasis in Nasopharyngeal Cancer Cells].

CD38 is a Putative Functional Marker for Side Population Cells in Human Nasopharyngeal Carcinoma Cell Lines

CD44 Splice Isoform Switching Determines Breast Cancer Stem Cell State